National Eye Institute; Notice of Closed Meeting, 40387-40388 [05-13824]
Download as PDF
<![CDATA[
Federal Register / Vol. 70, No. 133 / Wednesday, July 13, 2005 / Notices
Dated: July 5, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–13813 Filed 7–12–05; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel, Lab
Assessment of Tobacco Use Behavior &
Exposure Toxins.
Date: August 4, 2005.
Time: 8 a.m. to 4 p.m.
Agenda: To review and evaluate contract
proposals.
Place: Holiday Inn Select Bethesda, 8120
Wisconsin Ave, Bethesda, MD 20814.
Contact Person: Joyce C. Pegues, PhD,
Scientific Review Administrator, Special
Review and Logistics Branch, Division of
Extramural Activities, National Cancer
Institute, 6116 Executive Blvd. 7149,
Bethesda, MD 20892, 301/594–1286,
peguesj@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: July 5, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–13816 Filed 7–12–05; 8:45 am]
BILLING CODE 4140–01–M
VerDate jul<14>2003
17:40 Jul 12, 2005
Jkt 205001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Initial Review Group, Subcommittee
E—Cancer Epidemiology, Prevention &
Control.
Date: August 11–12, 2005.
Time: 8 a.m. to 12 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda North Marriott, 5701
Marinelli Road, North Bethesda, MD 20852.
Contact Person: Mary C. Fletcher, PhD,
Scientific Review Administrator, Research
Programs Review Branch, Division of
Extramural Activities, National Cancer
Institute, National Institutes of Health, 6116
Executive Boulevard, Rm 8115, Bethesda,
MD 20892, (301) 496–7413.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: July 5, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–13817 Filed 7–12–05; 8:45 am]
40387
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections 552(c)(4)
and 552b(c)(6), Title 5 U.S.C., as
amended. the grant applications and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center on
Minority Health and Health Disparities
Special Emphasis Panel, MCMHD
Community-Based Participatory Research &
Outreach.
Date: July 18–20, 2005.
Time: 2 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road, NW.,
Washington, DC 20015.
Contact Person: Merlyn M. Rodrigues, PhD,
MD, Director, Office of Extramural Activities,
National Center On Minority Health, and
Health Disparities, National Institute of
Health, 6707 Democracy Blvd. Suite 800,
Bethesda, MD 20894, (301) 402–1366,
rodrigm1@mail.nih.gov.
Name of Committee: National Center on
Minority Health and Health Disparities
Special Emphasis Panel, Project EXPORT—
Establishing Exploratory Centers.
Date: July 24–26, 2005.
Time: 5 p.m. to 2 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road, NW.,
Washington, DC 20015.
Contact Person: Lorrita Watson, PhD,
National Center on Minority Health and
Health Disparities, National Institutes of
Health, 6707 Democracy Blvd., Suite 800,
Bethesda, MD 20892–5465, 301–594–7784,
watsonl@ncmhd.nih.gov.
Dated: June 30, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–13811 Filed 7–12–05; 8:45 am]
BILLING CODE 4140–01–M
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Center on Minority Health and
Health Disparities; Notice of Closed
Meetings
Pursuant to section10(d) of the
Federal Advisory Committee Act, as
PO 00000
Frm 00081
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Eye Institute; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of a meeting of the
E:\FR\FM\13JYN1.SGM
13JYN1
40388
Federal Register / Vol. 70, No. 133 / Wednesday, July 13, 2005 / Notices
Board of Scientific Counselors, National
Eye Institute. The meeting will be
closed to the public as indicated below
in accordance with the provisions set
forth in section 552b(c)(6), Title 5
U.S.C., as amended for the review,
discussion, and evaluation of individual
intramural programs and projects
conducted by the National Eye Institute,
including consideration of personnel
qualifications and performance, and the
competence of individual
investigations, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Board of Scientific
Counselors, National Eye Institute.
Date: July 17–19, 2005.
Time: July 17, 2005, 7 p.m. to 10 p.m.
Agenda: To review and evaluate personal
qualifications and performance, and
competence of individual investigators.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Time: July 18, 2005, 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate personal
qualifications and performance, and
competence of individual investigators.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Conference
Room 8, Bethesda, MD 20892.
Time: July 19, 2005, 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate personal
qualifications and performance, and
competence of individual investigators.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Conference
Room 8, Bethesda, MD 20892.
Contact Person: Sheldon S. Miller, PhD,
Scientific Director, National Institutes of
Health, National Eye Institute, Bethesda, MD
20892, (301) 451–6763.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Information is also available on the
Institute’s/Center’s home page: https://
www.nei.nih.gov, where an agenda and any
additional information for the meeting will
be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.867, Vision Research,
National Institutes of Health, HHS)
Dated: July 5, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–13824 Filed 7–12–05; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly invasion of
personal privacy.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel,
Genetic Conditions.
Date: July 15, 2005.
Time: 1 p.m. to 4 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health, 6701
Rockledge drive, Bethesda, MD 20892,
(Telephone conference call.)
Contact Person: Valerie L. Prenger, PhD.,
Chief, Review Branch, Division of Extramural
Affairs, National Heart, Lung, and Blood
Institute, 6701 Rockledge Drive, MSC 7924,
Room 7214, Bethesda, MD 20892–7924. (301)
435–0270. prengerv@nhlbi.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Disease and
Resources Research, National Institutes of
Health, HHS)
Dated: July 5, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–13818 Filed 7–12–05; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Child Health and
Human Development; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
VerDate jul<14>2003
17:40 Jul 12, 2005
Jkt 205001
PO 00000
Frm 00082
Fmt 4703
Sfmt 4703
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Child Health and Human Development
Special Emphasis Panel, Amphetamine Use
in Stroke Recovery.
Date: August 4, 2005.
Time: 2 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6100
Executive Boulevard, Room 5B01, Rockville,
MD 20852, (Telephone Conference Call).
Contact Person: Kishena C. Wadhwani,
PhD, MPH, Scientific Review Administrator,
Division of Scientific Review, 9000 Rockville
Pike, MSC 7510, 6100 Building, Room 5B01,
Bethesda, MD 20892–7510, (301) 496–1485,
wadhwank@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.864, Population Research;
93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation
Research; 93.209, Contraception and
Infertility Loan Repayment Program, National
Institutes of Health, HHS)
Dated: July 7, 2005.
LaVerne, Y. Stringfield,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–13806 Filed 7–12–05; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Child Health and
Human Development; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
E:\FR\FM\13JYN1.SGM
13JYN1
]]>Agencies
[Federal Register Volume 70, Number 133 (Wednesday, July 13, 2005)]
[Notices]
[Pages 40387-40388]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-13824]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Eye Institute; Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of
the
[[Page 40388]]
Board of Scientific Counselors, National Eye Institute. The meeting
will be closed to the public as indicated below in accordance with the
provisions set forth in section 552b(c)(6), Title 5 U.S.C., as amended
for the review, discussion, and evaluation of individual intramural
programs and projects conducted by the National Eye Institute,
including consideration of personnel qualifications and performance,
and the competence of individual investigations, the disclosure of
which would constitute a clearly unwarranted invasion of personal
privacy.
Name of Committee: Board of Scientific Counselors, National Eye
Institute.
Date: July 17-19, 2005.
Time: July 17, 2005, 7 p.m. to 10 p.m.
Agenda: To review and evaluate personal qualifications and
performance, and competence of individual investigators.
Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400
Wisconsin Avenue, Bethesda, MD 20814.
Time: July 18, 2005, 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate personal qualifications and
performance, and competence of individual investigators.
Place: National Institutes of Health, Building 31, 31 Center
Drive, Conference Room 8, Bethesda, MD 20892.
Time: July 19, 2005, 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate personal qualifications and
performance, and competence of individual investigators.
Place: National Institutes of Health, Building 31, 31 Center
Drive, Conference Room 8, Bethesda, MD 20892.
Contact Person: Sheldon S. Miller, PhD, Scientific Director,
National Institutes of Health, National Eye Institute, Bethesda, MD
20892, (301) 451-6763.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Information is also available on the Institute's/Center's home
page: https://www.nei.nih.gov, where an agenda and any additional
information for the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.867,
Vision Research, National Institutes of Health, HHS)
Dated: July 5, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 05-13824 Filed 7-12-05; 8:45 am]
BILLING CODE 4140-01-M
